Article citationsMore>>

U.S. Food and Drug Administration (2016) Highlights of Prescribing Information: Lumason (Sulfur Hexafluoride Lipid-Type A Microspheres) for Injectable Supsension, for Intravenous or Intravesical Use.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203684s002lbl.pdf

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top